References
- Jacobi A, Antoni C, Manger B, et al. Infliximab in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 2005;52(3 Pt 1):522-6
- Yoon SY, Park HS, Lee JH, Cho S. Histological differentiation between palmoplantar pustulosis and pompholyx. Journal of the European Academy of Dermatology and Venereology : JEADV 2013;27(7):889-93
- Aydin O, Engin B, Oguz O, et al. Non-pustular palmoplantar psoriasis: is histologic differentiation from eczematous dermatitis possible? J Cutan Pathol 2008;35(2):169-73
- Guttman-Yassky E, Suarez-Farinas M, Chiricozzi A, et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol 2009;124(6):1235-44. e58
- Inkeles MS, Scumpia PO, Swindell WR, et al. Comparison of molecular signatures from multiple skin diseases identifies mechanisms of immunopathogenesis. J Invest Dermatol 2014. [Epub ahead of print]
- Eyerich S, Onken AT, Weidinger S, et al. Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 2011;365(3):231-8
- Quaranta M, Knapp B, Garzorz N, et al. Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci Transl Med 2014;6(244):244ra90
- Kanwar JR, Kanwar RK, Burrow H, Baratchi S. Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr Med Chem 2009;16(19):2373-94
- Lowes MA, Chamian F, Abello MV, et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 2005;102(52):19057-62
- Bruch-Gerharz D, Fehsel K, Suschek C, et al. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 1996;184(5):2007-12
- Ormerod AD, Weller R, Copeland P, et al. Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res 1998;290(1-2):3-8
- Nomura I, Gao B, Boguniewicz M, et al. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003;112(6):1195-202
- Bruch-Gerharz D, Schnorr O, Suschek C, et al. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol 2003;162(1):203-11
- Modolell M, Corraliza IM, Link F, et al. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 1995;25(4):1101-4
- Abeyakirthi S, Mowbray M, Bredenkamp N, et al. Arginase is overactive in psoriatic skin. Br J Dermatol 2010;163(1):193-6
- Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002;8(2):157-65
- Kakinuma T, Saeki H, Tsunemi Y, et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003;111(3):592-7
- Kagami S, Saeki H, Tsunemi Y, et al. CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli. Eur J Immunol 2008;38(3):647-57
- Chen L, Lin SX, Agha-Majzoub R, et al. CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model. Int Immunol 2006;18(8):1233-42
- Riis JL, Johansen C, Vestergaard C, et al. Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis. Exp Dermatol 2011;20(10):789-94
- Gudjonsson JE, Ding J, Johnston A, et al. Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol 2010;130(7):1829-40
- Kanda N, Koike S, Watanabe S. IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. J Allergy Clin Immunol 2005;116(5):1144-50
- Karakawa M, Komine M, Hanakawa Y, et al. CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes. J Cell Physiol 2014;229(12):1935-45
- Mildner M, Prior M, Gschwandtner M, et al. Epidermal CCL27 expression is regulated during skin development and keratinocyte differentiation. J Invest Dermatol 2014;134(3):855-8